COI

Co-directed by Professor Tak Mak and Professor Suet Yi Leung from HKUMed, Centre for Oncology and Immunology (https://www.coinno.hk/) aims to harness the power of biotechnology to develop innovative therapeutics to combat hard-to-treat malignancies and bring hope to millions of cancer patients around the world. 

The Centre’s research team comprises globally renowned researchers who bring with them a wealth of complementary expertise and experience in oncology research, technology adoption, and commercialisation. The Centre will employ novel functional screens as well as genomic and multi-omics techniques to identify novel "druggable" cancer targets. Leveraging the translational and clinical trial expertise of its lead scientists, the Centre will establish a number of advanced technical platforms to facilitate its overall goal of bringing candidate drugs and novel immunotherapy approaches into clinics.

Five major research programmes are developed under the centre to achieve the above objectives:

• Liver Cancer Research
• Gastrointestinal Cancer Research
• Hematopoietic Cancer Research
• Development of immuno-oncology approaches to treat cancer
• Development of advanced technical platforms for drug screening, biomarker discovery and drug development